Considerations and Concerns Regarding the Use of Ertapenem in Patients With Hypoalbuminemia : Is It Truly Inappropriate?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 78(2024), 2 vom: 17. Feb., Seite 488-489 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Phinder-Puente, Marian Elizabeth [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 19.02.2024 Date Revised 29.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciad558 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362180415 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362180415 | ||
| 003 | DE-627 | ||
| 005 | 20240331000656.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciad558 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1357.xml |
| 035 | |a (DE-627)NLM362180415 | ||
| 035 | |a (NLM)37721191 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Phinder-Puente, Marian Elizabeth |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Considerations and Concerns Regarding the Use of Ertapenem in Patients With Hypoalbuminemia |b Is It Truly Inappropriate? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.02.2024 | ||
| 500 | |a Date Revised 29.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Ertapenem |2 NLM | |
| 650 | 7 | |a G32F6EID2H |2 NLM | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a beta-Lactams |2 NLM | |
| 700 | 1 | |a Pérez-Nieto, Orlando Rubén |e verfasserin |4 aut | |
| 700 | 1 | |a Mondragón-Labelle, Tania Olga |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Barragán, Edgar |e verfasserin |4 aut | |
| 700 | 1 | |a Soto Muñoz, Leonardo |e verfasserin |4 aut | |
| 700 | 1 | |a Deloya-Tomas, Ernesto |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 78(2024), 2 vom: 17. Feb., Seite 488-489 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2024 |g number:2 |g day:17 |g month:02 |g pages:488-489 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciad558 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2024 |e 2 |b 17 |c 02 |h 488-489 | ||